Transarterial chemoembolization for patients with hepatocellular carcinoma.

about

MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab.Transcatheter arterial embolization in normal canine liver.

P2860

Q33555339-7F46DA20-528E-4D27-8F86-8B6AF4778C9A Q36068265-685CDE49-595C-4825-94CD-755F6ED419BF Q37449058-A3FB5B9D-2ADC-4F44-BDE3-1491B9C511E7 Q38756986-CB4584E7-0B16-4484-BC4D-17909BFDD6CA

P2860

Transarterial chemoembolization for patients with hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q51905707

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@en

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@nl

type

Item

label

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@en

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@nl

prefLabel

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@en

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@nl

P1476

Transarterial chemoembolization for patients with hepatocellular carcinoma.

@en

P2093

M Isabel Real

http://www.w3.org/2001/XMLSchema#string

Maria Varela

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.

A randomized clinical trial comparing autologous blood clot and gelfoam in transarterial chemoembolization for inoperable hepatocellular carcinoma.

Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever.

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

P304

S230-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1872-034X.2007.00190.X

http://www.w3.org/2001/XMLSchema#string

P478

37 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Alejandro Forner

Jordi Bruix

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17877488

http://www.w3.org/2001/XMLSchema#string

Transarterial chemoembolization for patients with hepatocellular carcinoma.

about

P2860

P2860

Transarterial chemoembolization for patients with hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698